miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 4, 2026

McDonald's Value Push New Under $3 Menu And $4 Breakfast Deal

View original at finance.yahoo.com
McDonald's Value Push New Under $3 Menu And $4 Breakfast Deal Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The market has already priced in substantial long term value creation and is also reacting to shorter term pressure on the business and consumer sentiment

    60% confidence
  • The company is shifting away from heavy digital couponing toward more predictable everyday pricing, with support from franchisees

    60% confidence
  • The degree to which customers respond to clearer everyday value, and how franchisee economics hold up under this pricing approach, are likely to be key themes to monitor in upcoming updates from the company

    60% confidence
  • If heavier value offers reduce restaurant level profitability, that would challenge the narrative that technology, scale and an asset light model alone are enough to offset cost pressures

    60% confidence
  • A simplified, standardized value ladder across the U.S. removes some of the complexity of digital-only discounts and makes it easier for customers to understand what they can get for a set spend

    60% confidence

Data points we hold from this source

McDonald's Corporation · stock return 30d-7.5 percent
McDonald's Corporation · stock return 5y49.4 percent
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com
McDonald's Value Push New Under $3 Menu And $4 Breakfast Deal — Source | Via News | es.VIA.NEWS